How to evaluate the immune status of lung cancer patients before immunotherapy Source: Breathe, 13 (4) 291; 10.1183/20734735.001917 Year: 2017
Determinants of lung cancer evolution: immune escape and inflammation Source: International Congress 2018 – Scientific Year in Review Year: 2018
How to define the immune status of lung cancer patient Source: International Congress 2015 – Stop immune tolerance in lung cancer! Year: 2015
The innate immune function of airway epithelial cells in inflammatory lung disease Source: Eur Respir J 2015; 45: 1150-1162 Year: 2015
Effects of tumor stroma and inflammation on survival of stage I-IIp lung cancer Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017
Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapy Source: Eur Respir J, 53 (3) 1801562; 10.1183/13993003.01562-2018 Year: 2019
MIP-3alpha gene therapy combined with localized radiation therapy boost anti-tumor immunity in a murine model of lung carcinoma Source: Eur Respir J 2005; 26: Suppl. 49, 328s Year: 2005
CAR T-cell therapy for lung cancer Source: International Congress 2017 – A novel approach to lung cancer Year: 2017
Immunology and defence mechanism of the developing lung Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=60 Year: 2006
Down regulation of type V collagen triggers angiogenesis and immune response disfunction in lung cancer microenvironment Source: Annual Congress 2010 - New insights in the pathology of lung cancer Year: 2010
pDC induced Treg proliferation through PD-1/PD-L1 signal and promote tumor immune escape of lung cancer with MPE Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014
Boosting immunotherapy in lung cancer Source: International Congress 2017 – ME9 Boosting immunotherapy in lung cancer Year: 2017
miRNAs and the regulation of the lung innate immune response Source: Annual Congress 2009 - miRNAs in inflammation and disease Year: 2009
Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer Source: Eur Respir Rev, 28 (153) 190058; 10.1183/16000617.0058-2019 Year: 2019
Splenectomy inhibits tumor development and metastases in murine lung cancer models Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
The status of populations of cell-mediated lung immunity effectors after chemotherapy of experimental MDR tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 656s Year: 2005
A case of pulmonary tuberculosis development after receiving immune check point inhibitor in an advanced non-small cell lung cancer Source: International Congress 2019 – Lung cancer? Year: 2019
Impact of antibiotics on immunotherapy response in lung cancer patients Source: International Congress 2019 – Treatment of lung cancer Year: 2019